Description
Tukysa 150mg tablet (tucatinib) is a targeted therapy used primarily to treat advanced or metastatic HER2-positive breast cancer.
Additional information
| Brand | Tukysa 150 |
|---|---|
| Generic name | Tucatinib tablets |
| Form | Oral tablets |
| Strength | 150mg |
| Packing | 84 tablets |
| Manufacturer | Seagen/Pfizer |
| Documents | Either PO or prescription |
| Storage | Below 25°C |
| Global delivery time | 10-15 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
Reviews
There are no reviews yet.